van der Geest R, Danhof M, Bodde HE
NIH-Funded Findings Inform Interdisciplinary Care Approach Across the Lifespan March 5, 2024 A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver
Reuters reports that the Medicines and Healthcare Products Regulatory Agency (MHRA) said in the statement that it was reviewing a class of drugs known as GLP-1 receptor agonists, sold by the company Novo Nordisk
What about alcohol and caffeine on GLP-1
During prolonged or intense exercise, the accumulation of metabolic byproducts such as lactic acid and the depletion of energy stores can impair the contractile function of muscle fibers
4 Additionally, research published in Diabetes Technology & Therapeutics found that initiating GLP-1 therapy in combination with CGM resulted in greater benefits than GLP-1 therapy alone
